Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uta Griesenbach

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
American Journal of Respiratory Cell and Molecular Biology|August 4, 2009
Limitations of the murine nose in the development of nonviral airway gene transferUta Griesenbach, Stephanie G Sumner-Jones, Emma Holder, et al.
Thorax|November 18, 2016
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosisEric W F W Alton, Jeffery M Beekman, A Christopher Boyd, et al.
The Lancet. Respiratory Medicine|July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trialEric W F W Alton, David K Armstrong, Deborah Ashby, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
American Journal of Respiratory Cell and Molecular Biology|August 4, 2009
Limitations of the murine nose in the development of nonviral airway gene transferUta Griesenbach, Stephanie G Sumner-Jones, Emma Holder, et al.
Thorax|November 18, 2016
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosisEric W F W Alton, Jeffery M Beekman, A Christopher Boyd, et al.
The Lancet. Respiratory Medicine|July 8, 2015
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trialEric W F W Alton, David K Armstrong, Deborah Ashby, et al.
Pageof 7